Investor Ideas Potcasts #597, Cannabis News and Stocks on the Move; (CSE: ORCD), (TSX: LABS), (TSX: XLY), (TSX: VLNS) (OTCQX: VLNCF)
Delta, Kelowna, BC - August 18, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts #597, Cannabis News and Stocks on the Move; (CSE: ORCD), (TSX: LABS), (TSX: XLY), (TSX: VLNS) (OTCQX: VLNCF)
Today's podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today's podcast we look at a few public and private company announcements.
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF), a pharmaceutical company that specializes in cannabis, announced that it has received approval to ship medical cannabis oil to Brazil. This approval, issued by both ANVISA and Health Canada, allows initial shipments to patients for the Company's partner XLR8. The shipment is a crucial milestone for the Company in using its pharmaceutical Good Manufacturing Practices ("GMP") platform for international manufacturing and distribution.
The Company and XLR8, a Curitiba based value-added distributor serving Brazil, entered into an agreement in September 2020. The two-year agreement is to commence from the time of ANVISA Sanitary Product Authorization, which is expected later this year. The registration will be for a mix of medical oil SKUs such as balanced and high CBD formulas. This initially approved delivery goes directly to patients under the compassionate care program, allowing XLR8 to begin its medical cannabis research. This first delivery opens a regulatory pathway for future opportunities for authorized product distribution. Brazil is one of the most significant medical cannabis market opportunities in LATAM.
"MediPharm Labs continues to execute our on plan to provide pharmaceutical-grade medical cannabis products to patients around the world. It is with great partners, like XLR8, with local country expertise that we can effectively achieve this goal," said Keith Strachan, President and Interim CEO, MediPharm Labs.
"Based on our business pillars, clinical research development is a strategic path to provide substantial clinical evidence to support physicians in making appropriate decisions in patient care and cannabis is a real alternative. Our clinical research follows all national and international ethical standards, demonstrating our responsibility to provide all necessary resources to our patients" said Thiago Callado, CEO and Founder, XLR8 BRAZIL.
The Company looks forward to announcing further executed deliveries to Brazil in the coming months.
Today, Back Forty - a cannabis brand from Auxly Cannabis Group Inc. (TSX: XLY), introduces Back Forty 40s, a new, straight-roll offering available now in Ontario at OSC.ca and at cannabis retail stores across the province. 40s are 0.35g single-strain, straight pre-rolls, machine rolled for a consistent, even burn with enhanced airflow and big flavour. Back Forty 40s launch with two high-potency cultivars - Animal Mints and Wedding Pie - and are presented in resealable, recyclable packages of 10, optimized for sharing out of the pack and preserving freshness. Back Forty is introducing 40s with an irreverent marketing campaign using Out-Of-Home advertising to encourage Canadians to unplug and embrace the outdoors by taking Mondays off through the summer. Back Forty 40s are the centrepiece of a summer of new product launches, which also features new dried flower strains and the brand's first edible offerings.
"We're thrilled to launch Back Forty 40s for Canada's savvy cannabis consumers, looking for high-quality products at affordable prices," said Brad Canario, Senior Director, Marketing, Auxly. "40s are a truly differentiated offering - leveraging state-of-the-art automation to deliver a straight pre-roll in packaging perfect for that last-minute camping trip or long day spent at the lake. For the launch of Back Forty 40s we wanted to make sure we had something unique in the market that delivered on the brand promise of recalling the simple joys found in nature. The Monday Merries is a challenge to all Canadians to focus on what really matters - getting outside - by including Mondays into the mix on the weekends throughout the rest of the summer."
Back Forty, Canada's #1 vape brandi, is launching 40s as the Canadian pre-roll market continues to grow. In 2020, pre-rolls were the second-largest product category in the Canadian market with 17% share of market. So far in 2021, pre-rolls have secured a 19.3% market share through June 30, 2021.ii
Back Forty 40s leverage Auxly genetics - the organically grown, high-potency strains Animal Mints and Wedding Pie. Animal Mints is a cross between Animal Cookies x SinMint Cookies, reaching potencies of up to 25%, with a total terpene content of up to 2.3%. Wedding Pie is the marriage of Wedding Cake x Grape Pie, reaching potencies of up to 26%, with up to 2.9% total terpene content.
This high-potency flower is machine rolled into 10 x 0.35g packages using first-of-its kind, state-of-the-art automation designed for consistency, an even burn and optimal air-flow and flavour. Each easy-to-share pack of 40s has a resealable film that locks in the freshness. And in true Back Forty fashion, 40s packaging is 100% recyclable. 40s are available in Ontario now, and will be coming soon to provinces across Canada.
Back Forty is launching 40s with an innovative Monday Merries campaign that flips the script on the negative stigma associated with Mondays. The campaign suggests that the greatest enjoyment is found by turning a Monday into a funday, so instead of going to work, Back Forty invites Canadians to explore their personal back forty, and, in doing so, reclaim the maligned day. The Monday Merries campaign includes social, digital and Out-Of-Home, with wild posting advertising soon to be live in major urban centres across Canada including Toronto, Vancouver, Calgary and Edmonton.
Back Forty 40s are only one of Back Forty's numerous product launches this summer, including new dried flower strains and the brand's first edibles, S'mores flavoured chocolates and Sour Cherry and Sour Grape soft chews. These new products will join Back Forty's already-popular lineup of vapes and flower, with more detail to follow in coming weeks.
The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF), a leading manufacturer of cannabis products, announced that it continues to prepare for international industry growth with upgrades to its leading-edge research and ISO/IEC 17025:2017 accredited testing facility, Valens Labs.
Valens Labs' testing capabilities have been enhanced to now further satisfy various additional international testing requirements for finished cannabis goods to support existing and future customers looking to expand their export capabilities. The enhanced validation methods that Valens Labs now offers are in preparation for changes in certain international analytics and testing requirements. These testing methods, which have previously been validated in all five tests required by Health Canada*, have been increased and are expected to be compliant for international standards in many emerging markets. Valens Labs is also CALA Certified, which is an internationally recognized leader in providing the highest-quality accreditation of laboratories.
Valens' third-party testing services now allows for the testing of more than 300 pesticides, making it the only cannabis testing lab in Canada with the capabilities to test this magnitude of contaminants at commercial capacity. This upgrade was made in anticipation of attracting more global business as testing standards evolve. The current Health Canada requirement mandates testing for 96 pesticides, however, testing beyond national requirements will further help customers achieve supreme sampling validation to ensure quality and safety. The testing capabilities upgrades will also continue to allow Valens to test and examine for terpenes, cannabinoid profiles, and microbials, and additional heavy metals such as zinc, nickel, and palladium.
"Our vision is to become a hub for international cannabis distribution and a launching pad for CPG companies who are ready to enter the market," said Tyler Robson, Chief Executive Officer, Co-Founder and Chair of The Valens Company. "Valens' fully validated ISO/IEC 17025:2017 accredited lab, one of the first in the Canadian cannabis industry, will expand our international export capabilities and contribute to the adoption of cannabis and cannabis products at an international level."
Robson continued, "We expect the regulatory standards for food and natural health products to require stricter and more demanding testing standards. As a result, Valens is preparing for the future by enabling worldwide manufacturing, distribution and exportation capabilities of the very best cannabis products."
These upgraded testing services will be available for Valens' broad customer base, which include Licensed Producers, individual producers, medicinal cannabis clients, and the natural wellness products industry.
Orchid Ventures, Inc. (CSE: ORCD) (OTC: ORVRF) announced that the Company has launched its proprietary new technology platform PurGuard, which it believes will have a significant impact on the usage of vape products by minors. Utilizing several key technologies and developing a proprietary software platform, the Company has developed an ecosystem for use in 510 thread cartridges and batteries, POD based systems, as well as disposable vaporizers.
A consumer that purchases a PurGuard product, will have to verify their age through a web-based and/or mobile application that pairs with the device via Bluetooth or USB cable. The device also has an auto-lock feature that when the registered user of the device is not near the device, the device can auto-lock, eliminating the possibility of a minor using the device. This technological advancement is believed by the Company to be perhaps the biggest advancement in vaporizer safety technology in over a decade.
"The PurGuard Platform is a major advancement in consumer safety and protection. It has been our mission from day one, to create the safest electronic cannabis delivery systems in the world, and with this advancement, we believe we have achieved another milestone in this mission. Being a software developer for over 20 years, coming up with software applications and taking them to market has been something I've personally excelled at for decades," said Corey Mangold, CEO of Orchid Ventures. "With this experience we have been able to create an ecosystem of hardware and software to achieve a significant level of protection, which can reduce and hopefully eliminate the usage of vaporizer products by minors. For our industry to truly succeed, we have to keep consumer safety at the forefront. We began this with emissions testing our products ensuring there were no harmful materials being inhaled, and now we have taken this level of safety and protection one significant step further. We believe that PurGuard will become an industry standard and we look forward to working with regulators to ensure that consumer safety is first and foremost."
With PurGuard products, a customer (brand) has the ability to "program" their cartridge, PODs or disposables with information from the lab reports such as brand, logo, strain name, potency, manufacture date and more. This allows users to know exactly what they are consuming when switching from cartridge to cartridge.
PurGuard products will be available to cannabis and CBD companies worldwide by Winter 2021.
These products will also be unveiled at MJ Biz Con in Las Vegas in mid October 2021.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea's original branded content includes podcasts and columns: Crypto Corner, Play by Play sports and stock news, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast, Cleantech and Climate Change, Exploring Mining, Betting on Gaming Stocks Podcast and the AI Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android